Skip to main content

Want a detailed portfolio tracker?

Performance analysis of Candel Therapeutics (CADL)

Annual Return

Over the past 3 years, CADL has had an average annual return of +79.26%, outperforming the benchmark SPY, which returned +22.45% annual.

Since Jul 27, 2021, CADL has had an average annual return of +4.83%, underperforming the benchmark SPY, which returned +13.31% annual.

202620252024202320222021
+55.76%-34.91%+490.48%-17.87%-77.11%+11.71%

Monthly Return

YearJanFebMarAprMayJunJulAugSepOctNovDecAnnually Total
2026+3.37%-10.10%-6.67%+26.13%+34.30%+6.02%+55.76%
2025-18.55%+26.94%-37.05%-13.10%+11.01%-7.15%+27.36%-10.17%-11.91%+5.49%-11.35%+18.45%-34.91%
2024-11.57%+43.08%-15.05%+346.21%+26.24%-30.34%-4.36%+13.84%+2.67%-23.81%-10.90%+84.50%+490.48%
2023+43.57%-29.96%-24.97%-4.46%+17.04%-16.55%-14.28%+12.96%-24.61%-2.13%-0.16%+63.55%-17.87%
2022-45.13%-3.96%+23.53%-29.67%+5.32%-14.05%-4.32%+11.92%-9.50%-38.23%-9.78%+2.28%-77.11%
2021+8.43%+5.93%+34.83%+3.60%-7.75%-24.52%+11.71%

Drawdown analysis of Candel Therapeutics (CADL)

The maximum drawdown for the CADL was -94.33%, occurring on Nov 3, 2023. Recovery took 132 trading sessions.

The current CADL drawdown is -37.14%.

Since Jul 27, 2021 CADL has experienced the following drawdowns:

  • 50% or more: 2 times
  • 40% or more: 2 times
  • 30% or more: 4 times
  • 20% or more: 4 times
  • 10% or more: 4 times
DepthStartTo BottomBottomTo RecoverEndTotal
-94.33%Oct 26, 2021509Nov 3, 2023132May 15, 2024641
-72.86%May 15, 2024128Nov 15, 2024OngoingOngoingOngoing
-36.31%Sep 8, 20218Sep 20, 202126Oct 26, 202134
-31.95%Aug 11, 20216Aug 19, 202112Sep 7, 202118
-1.57%Jul 27, 20211Jul 28, 20211Jul 29, 20212
-1.19%Jul 30, 20211Aug 2, 20216Aug 10, 20217